Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385715958> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4385715958 abstract "Anti-angiogenic agents could enhance tumor immunity response, and anti-angiogenesis plus immunotherapy has become a novel treatment option for advanced non-small cell lung cancer (NSCLC). The efficacy of this combination therapy remains controversial and obscure.We conducted a meta-analysis to evaluate the clinical efficacy and safety of this therapeutic strategy in patients with advanced NSCLC and provide more guidance for treating NSCLC clinically.A systematic literature search was performed in PubMed, Embase, Web of Science, CNKI, and Wanfang databases to identify relevant studies published up to December 2021. The primary endpoint was the objective response rate (ORR). Second endpoints were progression-free survival (PFS), overall survival (OS), and grade ≥3 AEs adverse events (AEs). The sensitivity analysis was conducted to confirm the stability of the results. STATA 15.0 was utilized for all pooled analyses.Eleven studies were eventually included in the meta-analysis, involving 533 patients with advanced NSCLC. The pooled ORR rate was 27% (95% CI 18% to 35%; I2 =84.2%; p<0.001), while the pooled median PFS and OS was 5.84 months (95% CI 4.66 to 7.03 months; I2=78.4%; p<0.001) and 14.20 months (95% CI 11.08 to 17.32 months; I2=82.2%; p=0.001), respectively. Most common grade ≥3 AEs included hypertension, hand-foot syndrome, diarrhea, adrenal insufficiency, hyponatremia, proteinuria, rash, thrombocytopenia, and fatigue.Anti-angiogenesis combined with immunotherapy demonstrated satisfactory antitumor activity and an acceptable toxicity profile in patients with advanced NSCLC. The pooled results of our meta-analysis provided further evidence supporting the favorable efficacy and safety of this therapeutic strategy." @default.
- W4385715958 created "2023-08-11" @default.
- W4385715958 creator A5004224153 @default.
- W4385715958 creator A5013052796 @default.
- W4385715958 creator A5031054509 @default.
- W4385715958 creator A5051763203 @default.
- W4385715958 creator A5052306677 @default.
- W4385715958 creator A5059739793 @default.
- W4385715958 creator A5061931792 @default.
- W4385715958 creator A5084747374 @default.
- W4385715958 date "2023-08-08" @default.
- W4385715958 modified "2023-09-27" @default.
- W4385715958 title "Anti-angiogenic agents combined with immunotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis" @default.
- W4385715958 doi "https://doi.org/10.2174/1386207326666230808112656" @default.
- W4385715958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37559541" @default.
- W4385715958 hasPublicationYear "2023" @default.
- W4385715958 type Work @default.
- W4385715958 citedByCount "0" @default.
- W4385715958 crossrefType "journal-article" @default.
- W4385715958 hasAuthorship W4385715958A5004224153 @default.
- W4385715958 hasAuthorship W4385715958A5013052796 @default.
- W4385715958 hasAuthorship W4385715958A5031054509 @default.
- W4385715958 hasAuthorship W4385715958A5051763203 @default.
- W4385715958 hasAuthorship W4385715958A5052306677 @default.
- W4385715958 hasAuthorship W4385715958A5059739793 @default.
- W4385715958 hasAuthorship W4385715958A5061931792 @default.
- W4385715958 hasAuthorship W4385715958A5084747374 @default.
- W4385715958 hasConcept C121608353 @default.
- W4385715958 hasConcept C126322002 @default.
- W4385715958 hasConcept C143998085 @default.
- W4385715958 hasConcept C197934379 @default.
- W4385715958 hasConcept C203092338 @default.
- W4385715958 hasConcept C2776256026 @default.
- W4385715958 hasConcept C2777701055 @default.
- W4385715958 hasConcept C2778570526 @default.
- W4385715958 hasConcept C2780030458 @default.
- W4385715958 hasConcept C2780739268 @default.
- W4385715958 hasConcept C3019894029 @default.
- W4385715958 hasConcept C535046627 @default.
- W4385715958 hasConcept C71924100 @default.
- W4385715958 hasConcept C95190672 @default.
- W4385715958 hasConceptScore W4385715958C121608353 @default.
- W4385715958 hasConceptScore W4385715958C126322002 @default.
- W4385715958 hasConceptScore W4385715958C143998085 @default.
- W4385715958 hasConceptScore W4385715958C197934379 @default.
- W4385715958 hasConceptScore W4385715958C203092338 @default.
- W4385715958 hasConceptScore W4385715958C2776256026 @default.
- W4385715958 hasConceptScore W4385715958C2777701055 @default.
- W4385715958 hasConceptScore W4385715958C2778570526 @default.
- W4385715958 hasConceptScore W4385715958C2780030458 @default.
- W4385715958 hasConceptScore W4385715958C2780739268 @default.
- W4385715958 hasConceptScore W4385715958C3019894029 @default.
- W4385715958 hasConceptScore W4385715958C535046627 @default.
- W4385715958 hasConceptScore W4385715958C71924100 @default.
- W4385715958 hasConceptScore W4385715958C95190672 @default.
- W4385715958 hasLocation W43857159581 @default.
- W4385715958 hasLocation W43857159582 @default.
- W4385715958 hasOpenAccess W4385715958 @default.
- W4385715958 hasPrimaryLocation W43857159581 @default.
- W4385715958 hasRelatedWork W2105795029 @default.
- W4385715958 hasRelatedWork W2314816973 @default.
- W4385715958 hasRelatedWork W2549481046 @default.
- W4385715958 hasRelatedWork W2904759734 @default.
- W4385715958 hasRelatedWork W2972494744 @default.
- W4385715958 hasRelatedWork W2972926806 @default.
- W4385715958 hasRelatedWork W3029766637 @default.
- W4385715958 hasRelatedWork W3207731879 @default.
- W4385715958 hasRelatedWork W4214692013 @default.
- W4385715958 hasRelatedWork W4285492859 @default.
- W4385715958 hasVolume "26" @default.
- W4385715958 isParatext "false" @default.
- W4385715958 isRetracted "false" @default.
- W4385715958 workType "article" @default.